Skip to main content
placeholder image

Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma

Journal Article


Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2013

Citation


  • Kim, M., Li, M., Intong, L. R. A., Tran, K., Melbourne, W., Marucci, D., . . . Murrell, D. F. (2013). Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. British Journal of Dermatology, 169(1), 208-210. doi:10.1111/bjd.12272

Scopus Eid


  • 2-s2.0-84879906192

Web Of Science Accession Number


Start Page


  • 208

End Page


  • 210

Volume


  • 169

Issue


  • 1

Abstract


UOW Authors


  •   De Souza, Paul (external author)

Publication Date


  • 2013

Citation


  • Kim, M., Li, M., Intong, L. R. A., Tran, K., Melbourne, W., Marucci, D., . . . Murrell, D. F. (2013). Use of cetuximab as an adjuvant agent to radiotherapy and surgery in recessive dystrophic epidermolysis bullosa with squamous cell carcinoma. British Journal of Dermatology, 169(1), 208-210. doi:10.1111/bjd.12272

Scopus Eid


  • 2-s2.0-84879906192

Web Of Science Accession Number


Start Page


  • 208

End Page


  • 210

Volume


  • 169

Issue


  • 1